GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (FRA:LIA) » Definitions » Future 3-5Y EPS without NRI Growth Rate

LivaNova (FRA:LIA) Future 3-5Y EPS without NRI Growth Rate : 8.00 (As of Apr. 02, 2025)


View and export this data going back to 2000. Start your Free Trial

What is LivaNova Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, LivaNova's Future 3-5Y EPS without NRI Growth Rate is 8.00.

Competitive Comparison of LivaNova's Future 3-5Y EPS without NRI Growth Rate

For the Medical Devices subindustry, LivaNova's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LivaNova's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where LivaNova's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

LivaNova  (FRA:LIA) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

LivaNova Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of LivaNova's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

LivaNova Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (FRA:LIA) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
ENOV NVCR TMDX QDEL CNMD SSII IART UFPT ATEC AHCO ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
LIVN:USA
Address
20 Eastbourne Terrace, London, GBR, W2 6LG
Website
https://www.livanova.com
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

LivaNova Headlines

No Headlines